Equity Research, Broker Reports, and media content on TIGENIX NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about TIGENIX NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on TIGENIX NV. We currently have 0 research reports from 0 professional analysts.

Open
0.70
Volume
0.2m
Range
0.70/0.70
Market Cap
175,799,661m
52 Week
0.60/1.20
Date Source Announcement
17Feb17 08:01 GNW Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601
06Feb17 06:30 GNW TiGenix announces acceptance of Cx601 abstract for oral presentation at 12th Congress of ECCO
31Jan17 06:02 GNW TiGenix Enrolls First Patient in Phase Ib/IIa Clinical Trial of Cx611 in Severe Sepsis
09Jan17 06:00 GNW Takeda notifies 4.48% shareholding in TiGenix
29Dec16 21:01 GNW TiGenix: Transparency Information
23Dec16 21:01 GNW TiGenix: notice in relation to the convertible bonds due 2018
22Dec16 21:01 GNW TiGenix Submits Day 120 Responses to European Medicines Agency for Cx601 Marketing Authorization
  • Frequency of research reports

     

  • Research reports on

    TIGENIX NV

  • Providers covering

    TIGENIX NV